PEN Penumbra, Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 30, 2026
$317,55
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$221,2652tyg. minimum
$362,4152tyg. maksimum
Kapitalizacja Rynkowa
$12.46B
P/E (TTM)
78.0
EPS (TTM)
$4.07
Przychody (TTM)
$1.50B
Twoje odznaki
Zakres 52 tyg.
$221–$362
Ocena Analityków
HOLD
Cena Docelowa
$362
P/E
78.0
ROE
11.4%
Marża Zysku Netto
10.7%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
PEN Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$317.55
Kapitalizacja Rynkowa
$12.46B
P/E (TTM)
78.0
EPS (TTM)
$4.07
Przychody (TTM)
$1.50B
ROE (TTM)
11.4%
Zakres 52 tyg.
$221–$362
PEN Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Penumbra, Inc. Common Stock Przegląd firmy z Wikipedii
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.
History
Penumbra was founded in 2004 and manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke.
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed.
In 2015 the company issued an initial public offering on the New York Stock Exchange. In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. In 2017 the company acquired the Italian distributor Crossmed.
Criticism
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. According to the Foundation for Financial Journalism, this is a significant dilemma.
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication.
Recalls
In 2011 the company recalled its Penumbra Coil 400. In 2017 the company recalled a 3D revascularization device. In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy4 700
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$1.40B2018-12-31 → 2025-12-31
EPS$4.522018-12-31 → 2025-12-31
Wolny przepływ pieniężny$175M2018-12-31 → 2025-12-31
Marża netto10.7%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | PEN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 78.0średnia z 5 lat ≈-312.0 | ≈-312.0 | 23.8 | Zawyżona wycena | |
| P/S | 8.9średnia z 5 lat ≈10.0 | ≈10.0 | 3.9 | Zawyżona wycena | |
| P/B | 8.7średnia z 5 lat ≈8.9 | ≈8.9 | 4.6 | Zawyżona wycena | |
| Price / FCF (Cena / FCF) | 71.2średnia z 5 lat ≈-157.5 | ≈-157.5 | · | · | |
| Price / Cash Flow (Cena / Przepływy pieniężne) | 52.2średnia z 5 lat ≈237.9 | ≈237.9 | 17.3 | Zawyżona wycena | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 9.9średnia z 5 lat ≈11.2 | ≈11.2 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | PEN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 67.8%średnia z 5 lat ≈64.3% | ≈64.3% | 62.3% | Najwyższa półka | |
| Marża Operacyjna (TTM) | 12.4%średnia z 5 lat ≈4.2% | ≈4.2% | 14.5% | Słaby | |
| Marża EBITDA (TTM) | 13.6%średnia z 5 lat ≈6.4% | ≈6.4% | 14.5% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 13.5%średnia z 5 lat ≈4.6% | ≈4.6% | 12.6% | Słaby | |
| Marża Zysku Netto (TTM) | 10.7%średnia z 5 lat ≈4.6% | ≈4.6% | 9.8% | Słaby | |
| ROA (TTM) | 8.8%średnia z 5 lat ≈3.6% | ≈3.6% | 7.8% | Najwyższa półka | |
| ROE (TTM) | 11.4%średnia z 5 lat ≈4.5% | ≈4.5% | 13.1% | Zgodnie z | |
| ROIC | 11.5%średnia z 5 lat ≈3.8% | ≈3.8% | 9.9% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | PEN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 5.7średnia z 5 lat ≈5.9 | ≈5.9 | 2.2 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 2.1średnia z 5 lat ≈2.2 | ≈2.2 | 1.1 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | PEN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 17.5%średnia z 5 lat ≈20.4% | ≈20.4% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 18.3%średnia z 5 lat ≈19.6% | ≈19.6% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 20.2% | · | · | · | |
| EPS YoY | 1155.6% | · | · | · | |
| Net Income YoY (Zysk Netto R/R) | 1168.1% | · | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 37.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 38.4% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | PEN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.8średnia z 5 lat ≈0.7 | ≈0.7 | 0.6 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 1.1średnia z 5 lat ≈1.1 | ≈1.1 | 1.8 | Słaby | |
| Receivables Turnover (Rotacja należności) | 7.8średnia z 5 lat ≈6.0 | ≈6.0 | 5.8 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$298.7K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-2.4%
Następny raport
Lis 03, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 27, 2026 | $0.88 | $1.20 | -26.6% |
| 31 marca 2026 | $0.82 | $1.09 | -24.5% | |
| 31 grudnia 2025 | $1.18 | $1.12 | 5.0% | |
| 30 września 2025 | $0.97 | $0.93 | 4.2% | |
| 30 czerwca 2025 | $0.86 | $0.83 | 3.6% | |
| 31 marca 2025 | $0.83 | $0.67 | 23.9% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Cost of Revenue | $461M | $440M | $376M | $312M | $272M | $222M | $175M | · | $117M | $92M | |
| Gross Profit | $942M | $755M | $683M | $535M | $475M | $338M | $372M | · | $217M | $171M | |
| R&D Expense | · | · | · | · | · | · | · | · | $32M | $24M | |
| SG&A Expense | $663M | $574M | $506M | $450M | $378M | $287M | $273M | · | $184M | $148M | |
| Operating Expenses | $753M | $746M | $609M | $529M | $483M | $377M | $324M | · | $216M | $172M | |
| Operating Income | $189M | $9M | $74M | $6M | $-8M | $-39M | $48M | · | $1M | $-1M | |
| Interest Expense | · | · | $2M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $16M | $14M | $7M | $2M | $3M | · | · | · | · | · | |
| Other Non-op | $893.0K | $-682.0K | $1M | $-2M | $-4M | $-343.0K | $-227.0K | · | $-1M | $-2M | |
| Pretax Income | $205M | $21M | $80M | $4M | $-11M | $-38M | $50M | · | $2M | $-869.0K | |
| Income Tax | $27M | $7M | $-11M | $6M | $-13M | $-19M | $3M | · | $-4M | $-16M | |
| Net Income | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| EPS (Basic) | $4.57 | $0.36 | $2.37 | $-0.05 | $0.14 | $-0.44 | $1.39 | · | $0.14 | $0.49 | |
| EPS (Diluted) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 | |
| Shares (Basic) | 38,918,493 | 38,633,744 | 38,401,171 | 37,841,874 | 36,764,290 | 35,766,892 | 34,750,706 | · | 32,978,065 | 30,464,583 | |
| Shares (Diluted) | 39,291,828 | 39,268,037 | 39,216,564 | 37,841,874 | 37,881,180 | 35,766,892 | 36,265,999 | · | 35,319,103 | 33,478,078 | |
| EBITDA | $207M | $33M | $101M | $30M | $9M | $-26M | $56M | · | $5M | $950.0K |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187M | $324M | $167M | $70M | $59M | $70M | $73M | · | $51M | $13M | |
| Short-term Investments | · | · | · | · | · | $195M | $117M | · | $164M | $116M | |
| Receivables | $190M | $168M | $202M | $203M | $134M | $115M | $106M | · | $58M | $43M | |
| Inventory | $432M | $407M | $388M | $334M | $264M | $220M | $153M | · | $95M | $73M | |
| Prepaid Expense | $50M | $37M | $36M | $30M | $29M | $19M | $15M | $12M | $15M | $19M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $7M | $9M | |
| Current Assets | $1.22B | $951M | $915M | $756M | $681M | $618M | $463M | $410M | $382M | $264M | |
| PP&E (Net) | $117M | $63M | $73M | $65M | $59M | $48M | $52M | · | $31M | $21M | |
| PP&E (Gross) | $194M | $137M | $132M | $113M | $97M | $78M | $73M | · | $41M | $28M | |
| Accum. Depreciation | $77M | $74M | $60M | $48M | $38M | $30M | $21M | · | $11M | $7M | |
| Goodwill | $167M | $166M | $166M | $166M | $166M | $8M | $8M | · | $8M | $0 | |
| Intangibles | $6M | $7M | $71M | $81M | $91M | $11M | $25M | · | $24M | $0 | |
| Other Non-current Assets | $41M | $41M | $26M | $13M | $13M | $9M | $3M | · | $1M | $487.0K | |
| Total Assets | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Accounts Payable | $35M | $31M | $27M | $27M | $13M | $14M | $15M | · | $7M | $4M | |
| Accrued Liabilities | $132M | $112M | $111M | $106M | $100M | $86M | $68M | $58M | $45M | $32M | |
| Current Liabilities | $183M | $158M | $151M | $145M | $123M | $106M | $91M | $70M | $52M | $36M | |
| Capital Leases | $183M | $187M | $197M | $199M | $137M | $44M | $47M | $47M | · | · | |
| Deferred Tax | · | · | · | · | · | · | $4M | · | $3M | $824.0K | |
| Other Non-current Liabilities | $12M | $15M | $5M | $3M | $4M | $8M | $15M | · | $18M | $824.0K | |
| Total Liabilities | $399M | $382M | $377M | $372M | $290M | $185M | $180M | $135M | $76M | $42M | |
| Common Stock | $39.0K | $38.0K | $39.0K | $38.0K | $37.0K | $36.0K | $35.0K | · | $33.0K | $31.0K | |
| Paid-in Capital | $1.19B | $1.10B | $1.05B | $963M | $911M | $598M | $431M | · | $397M | $274M | |
| Retained Earnings | $238M | $60M | $135M | $44M | $46M | $41M | $58M | · | $2M | $-3M | |
| AOCI | $4M | $-6M | $-3M | $-8M | $-3M | $3M | $-2M | · | $2M | $-5M | |
| Stockholders' Equity | $1.43B | $1.15B | $1.18B | $999M | $954M | $638M | $486M | · | $400M | $267M | |
| Liabilities + Equity | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Shares Outstanding | 39,229,670 | 38,490,836 | 38,681,549 | 38,107,977 | 37,578,483 | 36,414,732 | 35,001,581 | · | 33,685,146 | 31,108,828 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17M | $24M | $27M | $24M | $16M | $13M | $8M | · | $4M | $2M | |
| Stock-based Comp | $59M | $46M | $51M | $37M | $66M | $26M | $21M | · | $18M | $15M | |
| Deferred Tax | $21M | $-16M | $-25M | $1M | $-15M | $-20M | $1M | · | $-5M | $-13M | |
| Amort. of Intangibles | $712.0K | $5M | $10M | $9M | $3M | $1M | $1M | · | $418.0K | $0 | |
| Restructuring | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-37M | $101M | $-46M | $-116M | $-63M | $-36M | $-53M | · | $-9M | $-32M | |
| Operating Cash Flow | $239M | $168M | $97M | $-56M | $10M | $-33M | $27M | · | $13M | $-13M | |
| CapEx | $64M | $21M | $15M | $19M | $21M | $25M | $22M | · | $13M | $14M | |
| Investing Cash Flow | $-405M | $78M | $-16M | $55M | $-22M | $-104M | $-13M | · | $-78M | $687.0K | |
| Stock Issued | · | · | · | $0 | $0 | $135M | $0 | · | $106M | $0 | |
| Stock Repurchased | $0 | $100M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-100M | · | $0 | $0 | $135M | $0 | · | $106M | · | |
| Financing Cash Flow | $27M | $-87M | $16M | $12M | $836.0K | $135M | $-9M | · | $104M | $7M | |
| Net Change in Cash | $-138M | $157M | $98M | $10M | $-10M | $-3M | $5M | · | $37M | $-6M | |
| Taxes Paid | $15M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $175M | $147M | $82M | $-75M | $-12M | $-58M | $5M | · | $159.0K | $-26M | |
| Levered FCF | · | · | $80M | · | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | · | 65.1% | 64.9% | |
| Operating Margin | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% | -7.0% | 8.7% | · | 0.35% | -0.51% | |
| Net Margin | 12.7% | 1.2% | 8.6% | -0.24% | 0.71% | -2.8% | 8.8% | · | 1.4% | 5.6% | |
| Pretax Margin | 14.6% | 1.8% | 7.5% | 0.46% | -1.4% | -6.8% | 9.2% | · | 0.74% | -0.33% | |
| EBITDA Margin | 14.7% | 2.8% | 9.5% | 3.6% | 1.2% | -4.7% | 10.2% | · | 1.5% | 0.36% | |
| ROA | 10.6% | 0.91% | 6.2% | -0.15% | 0.49% | -2.1% | 7.9% | · | 1.2% | 4.8% | |
| ROE | 13.1% | 1.2% | 8.0% | -0.20% | 0.64% | -2.8% | 10.7% | · | 1.4% | 5.6% | |
| ROIC | 11.5% | 0.54% | 7.1% | -0.31% | 0.20% | -3.1% | 9.2% | · | 0.72% | 8.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 | 5.8 | 5.1 | · | 7.4 | 7.4 | |
| Quick Ratio | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 | 3.6 | 3.2 | · | 5.3 | 4.8 | |
| Interest Coverage | · | · | 42.3 | · | · | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | · | 1.4 | 1.4 | |
| Receivables Turnover | 7.8 | 6.5 | 5.2 | 5.0 | 5.5 | 5.1 | 5.8 | · | 6.6 | 7.2 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $36.39 | $29.90 | $30.48 | $26.21 | $25.38 | $17.62 | $13.88 | · | $11.89 | $8.57 | |
| Revenue / Share | $35.72 | $30.42 | $26.99 | $22.39 | $19.74 | $15.67 | $15.09 | · | $9.45 | $7.87 | |
| Cash Flow / Share | $6.07 | $4.29 | $2.48 | $-1.47 | $0.25 | $-0.93 | $0.73 | · | $0.36 | $-0.38 | |
| Cash / Share | $4.76 | $8.43 | $4.33 | $1.83 | $1.58 | $1.91 | $2.08 | · | $1.50 | $0.43 | |
| EPS (TTM) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.5% | 12.9% | 24.9% | 13.3% | 33.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.3% | 16.9% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.2% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1155.6% | -84.5% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 37.0% | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1168.1% | -84.6% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 38.4% | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Net Income TTM | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| Market Cap | $12.20B | $9.14B | $9.73B | $8.48B | $10.80B | $6.37B | $5.75B | · | $3.17B | $1.98B | |
| P/E | 68.8 | 659.7 | 108.4 | -4449.2 | 2052.3 | -397.7 | 122.6 | · | 723.8 | 145.0 | |
| P/S | 8.7 | 7.7 | 9.2 | 10.0 | 14.4 | 11.4 | 10.5 | · | 9.5 | 7.5 | |
| P/B | 8.5 | 7.9 | 8.3 | 8.5 | 11.3 | 9.9 | 11.8 | · | 7.9 | 7.4 | |
| P / Tangible Book | 9.7 | 9.3 | 10.3 | 11.3 | 15.5 | 10.3 | · | · | · | · | |
| P / Cash Flow | 51.1 | 54.3 | 100.0 | -152.3 | 1136.3 | -191.7 | 215.7 | · | 249.8 | -155.0 | |
| P / FCF | 69.7 | 62.1 | 118.5 | -113.1 | -924.6 | -109.9 | 1265.6 | · | 19935.7 | -75.1 | |
| Earnings Yield | 1.5% | 0.15% | 0.92% | -0.02% | 0.05% | -0.25% | 0.82% | · | 0.14% | 0.69% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $390M | $375M | $385M | $355M | $339M | $324M | $316M | $301M | $299M | $279M | $285M | $271M | $261M | $241M | $221M | $214M | |
| Cost of Revenue | $125M | $121M | $123M | $114M | $115M | $108M | $105M | $101M | $137M | $98M | $98M | $93M | $95M | $90M | $83M | $78M | |
| Gross Profit | $265M | $253M | $262M | $240M | $224M | $216M | $211M | $200M | $163M | $181M | $187M | $178M | $167M | $151M | $138M | $135M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $20M | · | $21M | |
| SG&A Expense | $199M | $193M | $181M | $169M | $160M | $153M | $148M | $140M | $142M | $144M | $130M | $126M | $127M | $123M | $116M | $109M | |
| Operating Expenses | $224M | $215M | $203M | $192M | $183M | $176M | $168M | $165M | $244M | $169M | $152M | $165M | $149M | $143M | $134M | $130M | |
| Operating Income | $41M | $38M | $59M | $49M | $41M | $40M | $43M | $35M | $-81M | $12M | $35M | $13M | $18M | $8M | $5M | $5M | |
| Interest Expense | · | · | · | · | · | · | · | · | $344.0K | $402.0K | · | · | $444.0K | $416.0K | · | · | |
| Interest Income | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $970.0K | · | · | |
| Other Non-op | $-456.0K | $-1M | $171.0K | $-535.0K | $812.0K | $445.0K | $-1M | $1M | $-226.0K | $-366.0K | $559.0K | $-444.0K | $808.0K | $90.0K | $2M | $-2M | |
| Pretax Income | $46M | $42M | $64M | $52M | $45M | $44M | $44M | $40M | $-78M | $15M | $38M | $13M | $20M | $9M | $7M | $3M | |
| Income Tax | $11M | $9M | $16M | $6M | $0 | $5M | $11M | $10M | $-18M | $4M | $-16M | $4M | $576.0K | $90.0K | $3M | $5M | |
| Net Income | $35M | $33M | $47M | $46M | $45M | $39M | $34M | $30M | $-60M | $11M | $54M | $9M | $19M | $9M | $4M | $-2M | |
| EPS (Basic) | $0.88 | $0.83 | $1.21 | $1.17 | $1.17 | $1.02 | $0.87 | $0.76 | $-1.55 | $0.28 | $1.42 | $0.24 | $0.49 | $0.22 | $0.11 | $-0.06 | |
| EPS (Diluted) | $0.88 | $0.82 | $1.20 | $1.17 | $1.15 | $1.00 | $0.88 | $0.75 | $-1.55 | $0.28 | $1.39 | $0.23 | $0.48 | $0.22 | $0.11 | $-0.06 | |
| Shares (Basic) | 39,353,965 | 39,275,424 | · | 39,078,378 | 38,834,917 | 38,562,191 | · | 38,610,805 | 38,793,341 | 38,717,334 | 38,628,565 | 38,462,463 | 38,320,999 | 38,186,342 | 38,030,344 | 37,918,452 | |
| Shares (Diluted) | 39,572,059 | 39,543,780 | · | 39,302,239 | 39,245,953 | 39,163,428 | · | 39,178,227 | 38,793,341 | 39,387,359 | 39,291,044 | 39,219,966 | 39,201,155 | 39,075,388 | 38,896,940 | 37,918,452 | |
| EBITDA | $41M | $43M | · | $49M | $41M | $45M | · | $35M | $-81M | $20M | · | $13M | $18M | $15M | · | $5M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $241M | $187M | $321M | $422M | $376M | $324M | $280M | $288M | $223M | · | $101M | $114M | $95M | · | $55M | |
| Receivables | $190M | $183M | $190M | $183M | $176M | $168M | $168M | $176M | $201M | $192M | · | $207M | $209M | $207M | · | $189M | |
| Inventory | $443M | $439M | $432M | $432M | $428M | $416M | $407M | $393M | $374M | $398M | · | $374M | $359M | $344M | · | $320M | |
| Prepaid Expense | $52M | $38M | $50M | $55M | $38M | $37M | $37M | $31M | $29M | $31M | · | $39M | $39M | $36M | · | $30M | |
| Current Assets | $1.34B | $1.28B | $1.22B | $1.14B | $1.07B | $1000M | $951M | $892M | $944M | $935M | · | $868M | $828M | $786M | · | $724M | |
| PP&E (Net) | $147M | $134M | $117M | $98M | $85M | $72M | $63M | $60M | $58M | $76M | · | $66M | $66M | $65M | · | $64M | |
| PP&E (Gross) | · | · | $194M | · | · | · | $137M | $132M | $143M | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $77M | · | · | · | $74M | $72M | $85M | · | · | · | · | · | · | · | |
| Goodwill | $167M | $167M | $167M | $167M | $167M | $166M | $166M | $166M | $166M | $166M | · | $166M | $166M | $166M | · | $165M | |
| Intangibles | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $68M | · | $73M | $76M | $79M | · | $83M | |
| Other Non-current Assets | $41M | $41M | $41M | $40M | $40M | $44M | $41M | $39M | $39M | $34M | · | $15M | $10M | $11M | · | $13M | |
| Total Assets | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Accounts Payable | $45M | $44M | $35M | $30M | $28M | $31M | $31M | $33M | $33M | $32M | · | $28M | $26M | $28M | · | $25M | |
| Accrued Liabilities | $172M | $152M | $132M | $124M | $114M | $113M | $112M | $106M | $104M | $107M | · | $104M | $106M | $106M | · | $102M | |
| Current Liabilities | $234M | $212M | $183M | $170M | $158M | $159M | $158M | $153M | $151M | $153M | · | $145M | $144M | $146M | · | $138M | |
| Capital Leases | $176M | $179M | $183M | $180M | $183M | $185M | $187M | $190M | $192M | $195M | · | $192M | $195M | $197M | · | $181M | |
| Other Non-current Liabilities | $14M | $13M | $12M | $15M | $18M | $16M | $15M | $9M | $8M | $6M | · | $3M | $3M | $3M | · | $3M | |
| Total Liabilities | $444M | $425M | $399M | $386M | $381M | $380M | $382M | $375M | $373M | $376M | · | $364M | $366M | $371M | · | $348M | |
| Common Stock | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | $39.0K | $39.0K | · | $38.0K | $38.0K | $38.0K | · | $38.0K | |
| Paid-in Capital | $1.22B | $1.20B | $1.19B | $1.17B | $1.15B | $1.12B | $1.10B | $1.08B | $1.08B | $1.06B | · | $1.03B | $1.00B | $979M | · | $947M | |
| Retained Earnings | $305M | $270M | $238M | $190M | $144M | $99M | $60M | $26M | $86M | $146M | · | $81M | $71M | $52M | · | $40M | |
| AOCI | $1M | $2M | $4M | $3M | $3M | $-3M | $-6M | $-963.0K | $-5M | $-5M | · | $-7M | $-6M | $-7M | · | $-13M | |
| Stockholders' Equity | $1.53B | $1.47B | $1.43B | $1.36B | $1.29B | $1.21B | $1.15B | $1.10B | $1.16B | $1.20B | $1.18B | $1.10B | $1.07B | $1.02B | $999M | $974M | |
| Liabilities + Equity | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Shares Outstanding | · | · | 39,229,670 | · | · | · | 38,490,836 | · | · | · | · | · | · | · | · | · |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $4M | $2M | $6M | $5M | $4M | $4M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | |
| Stock-based Comp | $14M | $15M | $15M | $16M | $14M | $14M | $12M | $11M | $10M | $14M | $11M | $14M | $13M | $13M | $10M | $10M | |
| Amort. of Intangibles | $181.0K | $182.0K | $182.0K | $182.0K | $178.0K | $170.0K | $170.0K | $176.0K | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $35M | · | · | · | $-9M | · | · | · | $6M | · | · | · | $-15M | · | · | |
| Operating Cash Flow | $46M | $87M | $86M | $58M | $45M | $49M | $51M | $56M | $23M | $38M | $36M | $31M | $17M | $13M | $1M | $-13M | |
| CapEx | $14M | $14M | $18M | $16M | $16M | $13M | $5M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $4M | $6M | |
| Investing Cash Flow | $-91M | $-31M | $-226M | $-163M | $-16M | $-502.0K | $-11M | $36M | $34M | $18M | $24M | $-44M | $-7M | $11M | $9M | $10M | |
| Stock Repurchased | · | · | $0 | · | · | · | $-1.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $9M | $-2M | $5M | $4M | $15M | $3M | $6M | $-101M | $8M | $-794.0K | $6M | $212.0K | $9M | $1M | $6M | $-603.0K | |
| Net Change in Cash | $-36M | $54M | $-134M | $-101M | $46M | $52M | $44M | $-8M | $65M | $56M | $67M | $-13M | $19M | $25M | $15M | $-3M | |
| Free Cash Flow | · | $73M | · | · | · | $36M | · | · | · | $32M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $32M | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 67.6% | · | 67.8% | 66.0% | 66.6% | · | 66.5% | 54.4% | 65.0% | · | 65.6% | 63.8% | 62.6% | · | 63.3% | |
| Operating Margin | 10.5% | 10.2% | · | 13.8% | 12.0% | 12.4% | · | 11.8% | -27.0% | 4.3% | · | 4.7% | 6.8% | 3.3% | · | 2.5% | |
| Net Margin | 8.9% | 8.7% | · | 12.9% | 13.3% | 12.1% | · | 9.8% | -20.1% | 4.0% | · | 3.4% | 7.2% | 3.5% | · | -1.1% | |
| Pretax Margin | 11.8% | 11.1% | · | 14.8% | 13.4% | 13.5% | · | 13.2% | -26.0% | 5.2% | · | 4.9% | 7.5% | 3.6% | · | 1.4% | |
| EBITDA Margin | 10.5% | 11.4% | · | 13.8% | 12.0% | 14.0% | · | 11.8% | -27.0% | 7.0% | · | 4.7% | 6.8% | 6.0% | · | 2.5% | |
| ROA | 1.9% | 1.9% | · | 2.8% | 2.8% | 2.5% | · | 2.0% | -4.1% | 0.74% | · | 0.66% | 1.4% | 0.63% | · | -0.20% | |
| ROE | 2.5% | 2.4% | · | 3.7% | 3.7% | 3.2% | · | 2.7% | -5.4% | 0.99% | · | 0.89% | 1.9% | 0.86% | · | -0.27% | |
| ROIC | 2.0% | 2.0% | · | 3.1% | 3.2% | 3.0% | · | 2.4% | -5.4% | 0.76% | · | 0.79% | 1.6% | 0.77% | · | -0.42% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.0 | · | 6.7 | 6.8 | 6.3 | · | 5.8 | 6.3 | 6.1 | · | 6.0 | 5.7 | 5.4 | · | 5.2 | |
| Quick Ratio | 1.7 | 2.0 | · | 3.0 | 3.8 | 3.4 | · | 3.0 | 3.2 | 2.7 | · | 2.1 | 2.2 | 2.1 | · | 1.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -235.4 | 30.1 | · | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 2.1 | 2.1 | · | 2.0 | 1.8 | 1.8 | · | 1.6 | 1.5 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.4 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $9.86 | $9.48 | · | $9.02 | $8.65 | $8.28 | · | $7.68 | $7.72 | $7.07 | · | $6.91 | $6.67 | $6.18 | · | $5.64 | |
| Cash Flow / Share | · | $2.20 | · | · | · | $1.25 | · | · | · | $0.97 | · | · | · | $0.34 | · | · | |
| EPS (TTM) | $4.07 | $4.34 | · | $4.20 | $3.78 | $1.08 | · | $0.87 | $0.35 | $2.38 | · | $1.04 | $0.75 | $0.17 | · | $-0.83 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.50B | $1.45B | · | $1.33B | $1.28B | $1.24B | · | $1.16B | $1.13B | $1.10B | · | $995M | $938M | $885M | · | $830M | |
| Net Income TTM | $161M | $171M | · | $164M | $148M | $42M | · | $35M | $14M | $93M | · | $41M | $29M | $6M | · | $-31M | |
| P/E | 77.6 | 75.7 | · | 60.3 | 67.9 | 247.6 | · | 223.3 | 514.2 | 93.8 | · | 232.6 | 458.7 | 1639.4 | · | -228.4 | |
| Earnings Yield | 1.3% | 1.3% | · | 1.7% | 1.5% | 0.40% | · | 0.45% | 0.19% | 1.1% | · | 0.43% | 0.22% | 0.06% | · | -0.44% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $1.40B | $1.19B | $1.06B | $847M | $748M |
| Marża Brutto % | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% |
| Marża Operacyjna % | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% |
| Zysk netto | $178M | $14M | $91M | $-2M | $5M |
| Rozwodniony EPS | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 |
| Wskaźnik Szybkości | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $175M | $147M | $82M | $-75M | $-12M |
Właściciele instytucjonalni (13F) 490 emitentów · $12.1B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
490
Wartość posiadanych akcji
$12.1B
Nowe pozycje
46
Zamknięte pozycje
67
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 46 (-96 vs poprzedni kw.) | 67 (-9 vs poprzedni kw.) | 148 (-1 vs poprzedni kw.) | 186 (+50 vs poprzedni kw.) | +877K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $1 356 952 992 | 4 297 555 | 11,19% | Akcje |
| VANGUARD GROUP INC | $1 172 307 607 | 3 770 569 | 9,67% | Akcje |
| HBK INVESTMENTS L P | $580 508 901 | 1 838 508 | 4,79% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $539 893 663 | 1 709 877 | 4,45% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $526 442 397 | 1 667 276 | 4,34% | Akcje |
| STATE STREET CORP | $392 556 505 | 1 243 258 | 3,24% | Akcje |
| ExodusPoint Capital Management, LP | $344 303 272 | 1 090 430 | 2,84% | Akcje |
| Balyasny Asset Management L.P. | $344 218 967 | 1 090 163 | 2,84% | Akcje |
| JPMORGAN CHASE & CO | $338 557 982 | 1 071 454 | 2,79% | Akcje |
| GOLDMAN SACHS GROUP INC | $267 473 088 | 847 104 | 2,21% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $263 620 622 | 834 903 | 2,17% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $251 546 090 | 796 471 | 2,07% | Akcje |
| NORGES BANK | $237 520 412 | 752 242 | 1,96% | Akcje |
| UBS Group AG | $222 231 798 | 703 822 | 1,83% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $221 217 923 | 700 611 | 1,82% | Akcje |
| MORGAN STANLEY | $186 869 151 | 591 824 | 1,54% | Akcje |
| AQR Arbitrage LLC | $178 042 900 | 563 873 | 1,47% | Akcje |
| WHITEBOX ADVISORS LLC | $160 047 676 | 506 881 | 1,32% | Akcje |
| Capital World Investors | $151 465 591 | 479 701 | 1,25% | Akcje |
| CITADEL ADVISORS LLC | $141 696 917 | 448 763 | 1,17% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $138 473 110 | 438 553 | 1,14% | Akcje |
| CITIGROUP INC | $136 759 219 | 433 125 | 1,13% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $135 181 416 | 428 128 | 1,11% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $126 504 922 | 400 649 | 1,04% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $108 527 380 | 343 713 | 0,89% | Akcje |
| NORTHERN TRUST CORP | $105 164 958 | 333 064 | 0,87% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $102 972 179 | 326 120 | 0,85% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $99 031 466 | 301 585 | 0,82% | Akcje |
| BANK OF AMERICA CORP /DE/ | $83 994 867 | 266 017 | 0,69% | Akcje |
| Invesco Ltd. | $83 351 684 | 263 980 | 0,69% | Akcje |
| Magnetar Financial LLC | $80 781 796 | 255 841 | 0,67% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $79 488 800 | 251 746 | 0,66% | Akcje |
| Bank of New York Mellon Corp | $74 304 811 | 235 328 | 0,61% | Akcje |
| Champlain Investment Partners, LLC | $69 159 354 | 219 032 | 0,57% | Akcje |
| TIG Advisors, LLC | $67 912 141 | 215 082 | 0,56% | Akcje |
| LMR Partners LLP | $67 536 715 | 213 893 | 0,56% | Akcje |
| FMR LLC | $66 623 786 | 211 002 | 0,55% | Akcje |
| Hudson Bay Capital Management LP | $64 140 823 | 203 138 | 0,53% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $63 150 000 | 200 000 | 0,52% | Opcja sprzedaży |
| D. E. Shaw & Co., Inc. | $62 306 632 | 197 329 | 0,51% | Akcje |
| ALPINE ASSOCIATES MANAGEMENT INC. | $59 672 330 | 188 986 | 0,49% | Akcje |
| Melqart Asset Management (UK) Ltd | $58 645 511 | 185 734 | 0,48% | Akcje |
| CAXTON ASSOCIATES LLP | $56 640 498 | 179 384 | 0,47% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $55 799 340 | 176 720 | 0,46% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55 540 425 | 175 900 | 0,46% | Opcja sprzedaży |
| JANUS HENDERSON GROUP PLC | $54 849 328 | 167 054 | 0,45% | Akcje |
| Birnam Oak Advisors, LP | $54 080 713 | 171 277 | 0,45% | Akcje |
| Westchester Capital Management, LLC | $49 721 784 | 157 472 | 0,41% | Akcje |
| WATER ISLAND CAPITAL LLC | $47 506 483 | 150 456 | 0,39% | Akcje |
| Woodline Partners LP | $46 050 243 | 145 844 | 0,38% | Akcje |
Insiderzy spółki 19 insiderów · 5 dyrektorzy generalni · 7 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Adam Elsesser | CEO | 19 maja 2026 G | 683 042 | 0 | 0 | $0 |
| Maggie Yuen | Chief Financial Officer | 15 marca 2026 F | 18 167 | 0 | 1 | $-832 474 |
| Shruthi Narayan | President | 15 września 2026 F | 32 650 | 0 | 0 | $0 |
| Lambert Shiu | Chief Accounting Officer | 15 marca 2026 F | 39 323 | 0 | 0 | $0 |
| Johanna Roberts | EVP, Gen. Counsel & Secretary | 15 marca 2026 F | 67 298 | 0 | 29 | $-1 117 125 |
| Surbhi Sarna | Dyrektor | 13 lutego 2026 A | 4 293 | 0 | 0 | $0 |
| Janet Leeds | Dyrektor | 13 lutego 2026 A | 6 639 | 0 | 0 | $0 |
| Bridget O'Rourke | Dyrektor | 13 lutego 2026 A | 5 962 | 0 | 0 | $0 |
| Arani Bose | Dyrektor | 13 lutego 2026 A | 1 147 | 0 | 10 | $-9 062 931 |
| Thomas Wilder | Dyrektor | 13 lutego 2026 A | 589 | 0 | 2 | $-105 025 |
| Walter Charles Wang | Dyrektor | 4 marca 2016 A | 521 071 | 0 | 0 | $0 |
| Harpreet Grewal | · | 2 kwietnia 2026 S | 8 719 | 0 | 5 | $-208 842 |
| Don W. Kassing | · | 14 lutego 2025 A | 1 409 | 0 | 0 | $0 |
| James Robert Pray | · | 1 października 2021 S | 408 431 | 0 | 0 | $0 |
| Lynn Rothman | · | 1 października 2021 M | 32 637 | 0 | 0 | $0 |
| Sridhar Kosaraju | · | 15 kwietnia 2020 S | 155 351 | 0 | 0 | $0 |
| Daniel Donen Davis | · | 27 grudnia 2018 M | 64 277 | 0 | 0 | $0 |
| Robert D. Evans | · | 30 sierpnia 2018 M | 15 667 | 0 | 0 | $0 |
| Kevin James Sullivan | · | 31 sierpnia 2016 S | 29 449 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 67 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| RSBA · Tidal Trust II | 4,65% | 7 617 NS | 31 lipca 2026 | N-PORT |
| NEWZ · EA Series Trust | 3,43% | 2 085 NS | 31 lipca 2026 | N-PORT |
| MNA · New York Life Investments ETF Trust | 2,11% | 16 553 NS | 31 lipca 2026 | N-PORT |
| IHI · iShares Trust | 1,88% | 188 033 SH | 11 września 2026 | Dziennie |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,65% | 3 558 NS | 31 lipca 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,96% | 9 963 SH | 30 września 2026 | Dziennie |
| MEDI · Harbor ETF Trust | 0,77% | 987 NS | 31 lipca 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,65% | 38 809 SH | 19 sierpnia 2026 | Dziennie |
| IQSM · New York Life Investments ETF Trust | 0,46% | 4 773 NS | 31 lipca 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0,43% | 712 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,40% | 12 024 SH | 11 września 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,39% | 15 774 NS | 31 lipca 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,36% | 4 350 NS | 31 lipca 2026 | N-PORT |
| IWP · iShares Trust | 0,36% | 214 670 SH | 11 września 2026 | Dziennie |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,34% | 63 544 SH | 19 sierpnia 2026 | Dziennie |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 495 123 SH | 19 sierpnia 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,31% | 6 335 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 4 348 NS | 31 lipca 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,29% | 1 182 NS | 31 lipca 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,27% | 578 NS | 31 lipca 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 16 632 NS | 31 lipca 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 18 226 NS | 31 lipca 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 50 475 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 0,19% | 22 263 SH | 11 września 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 17 746 NS | 31 lipca 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 13 412 NS | 31 lipca 2026 | N-PORT |
| ESML · iShares Trust | 0,17% | 15 152 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,17% | 112 334 SH | 19 sierpnia 2026 | Dziennie |
| SMMD · iShares Trust | 0,17% | 20 300 SH | 11 września 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,15% | 12 580 SH | 30 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,14% | 451 358 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,14% | 856 800 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,12% | 59 193 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,11% | 2 287 SH | 11 września 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 2 371 SH | 1 października 2026 | Dziennie |
| IWR · iShares Trust | 0,09% | 156 309 SH | 11 września 2026 | Dziennie |
| RILA · Spinnaker ETF Series | 0,07% | 88 NS | 31 lipca 2026 | N-PORT |
| XT · iShares Trust | 0,07% | 8 117 SH | 11 września 2026 | Dziennie |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 2 477 SH | 1 października 2026 | Dziennie |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 60 327 SH | 19 sierpnia 2026 | Dziennie |
| IWF · iShares Trust | 0,04% | 143 096 SH | 11 września 2026 | Dziennie |
| IUSG · iShares Trust | 0,03% | 35 012 SH | 11 września 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,03% | 3 843 SH | 1 października 2026 | Dziennie |
| TILT · FlexShares Trust | 0,02% | 1 422 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1 186 275 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 6 349 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 3 208 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,02% | 8 611 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,02% | 27 709 NS | 31 lipca 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 1 685 SH | 10 września 2026 | Dziennie |
| IWB · iShares Trust | 0,02% | 26 117 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,02% | 50 889 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,02% | 10 594 SH | 10 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,02% | 6 022 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 9 928 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 1 400 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 810 NS | 31 lipca 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 30 658 SH | 19 sierpnia 2026 | Dziennie |
| EPU · iShares Trust | 0,00% | 19 935 SH | 11 września 2026 | Dziennie |
| DYNF · BlackRock ETF Trust | 0,00% | 42 SH | 24 sierpnia 2026 | Dziennie |
| EEMS · iShares, Inc. | 0,00% | 100 SH | 26 sierpnia 2026 | Dziennie |
| IJH · iShares Trust | · | 1 380 497 SH | 11 września 2026 | Dziennie |
| IJK · iShares Trust | · | 228 092 SH | 11 września 2026 | Dziennie |
| XJH · iShares Trust | · | 5 373 SH | 8 września 2026 | Dziennie |
| ISCB · iShares Trust | · | 1 708 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 10 495 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 5 954 SH | 1 września 2026 | Dziennie |
PEN Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 20 analityków
TRZYMAJ
Średni cel
$374.00
+17,8%
1 5,0%
Mocne kupno
5 25,0%
Kup
14 70,0%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
12 analityków · 2026-10-02Średnia cel $361.83 +13,9%
← Poniżej wszystkich celów
Aktualna cena $317.55
Niski$323.00
Średnia$361.83
Wysoki$374.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 30, 2026